# A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease

> **NCT01458470** · PHASE2 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 19 (actual)

## Conditions studied

- Huntington Disease

## Interventions

- **DRUG:** Memantine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01458470
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-08
- **Final completion:** 2012-11
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-01-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458470, "A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01458470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*